共 20 条
[1]
[2]
[3]
[4]
[5]
[6]
[7]
Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis[J] Michele Malaguarnera;Marco Vacante;Tijana Antic;Maria Giordano;Giuseppe Chisari;Rosaria Acquaviva;Silvana Mastrojeni;Giulia Malaguarnera;Antonio Mistretta;Giovanni Volti;Fabio Galvano Digestive Diseases and Sciences 2012,
[8]
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis[J] Vlad Ratziu;Victor de Ledinghen;Fréderic Oberti;Philippe Mathurin;Claire Wartelle-Bladou;Christophe Renou;Philippe Sogni;Marianne Maynard;Dominique Larrey;Lawrence Serfaty;Dominique Bonnefont-Rousselot;Jean-Philippe Bastard;Marc Rivière;Jean Spénard Journal of Hepatology 2011,
[9]
High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double‐blind; randomized; placebo‐controlled trial[J] Ulrich F. H. Leuschner;Birgit Lindenthal;Günter Herrmann;Joachim C. Arnold;Martin R?ssle;Hans‐J?rg Cordes;Stefan Zeuzem;Jasper Hein;Thomas Berg Hepatology 2010,
[10]
A meta‐analysis of randomized trials for the treatment of nonalcoholic fatty liver disease[J] Giovanni Musso;Roberto Gambino;Maurizio Cassader;Gianfranco Pagano Hepatology 2010,

